The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loppnow, H.
Right arrow Articles by Flad, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loppnow, H.
Right arrow Articles by Flad, H. D.

The Journal of Immunology, Vol 142, Issue 9 3229-3238, Copyright © 1989 by American Association of Immunologists

ARTICLES

IL-1 induction-capacity of defined lipopolysaccharide partial structures

H Loppnow, H Brade, I Durrbaum, CA Dinarello, S Kusumoto, ET Rietschel and HD Flad
Department of Immunologie, Forschungsinstitut Borstel, FRG.

Natural and synthetic lipid A as well as natural and synthetic oligosaccharide partial structures of LPS were examined in dose- response experiments to define the minimal structure necessary for IL-1 induction and release in cultures of human mononuclear cells. Wild type LPS (S. abortus equi) and rough mutant LPS was active in minimal-doses of 1 to 100 pg/ml, whereas synthetic heptaacyl and hexaacyl lipid A (Salmonella minnesota and Escherichia coli lipid A, respectively) induced IL-1 in minimal-doses of 100 to 1,000 pg/ml and 10 to 1,000 pg/ml, respectively. Nanogram amounts (0.1 to 10 ng/ml) of synthetic monodephospho partial structures of E. coli lipid A were necessary for IL-1 induction. Synthetic pentaacyl partial structures induced IL-1 very weakly. Synthetic tetraacyl and bisacyl partial structures lacking non-hydroxylated fatty acids were not active. Compared to LPS million- fold higher doses of natural and synthetic 3-deoxy-D-manno-octulosonic acid containing core oligosaccharides were necessary for IL-1 induction. Dose-response investigations with LPS and natural or synthetic partial structures established the following hierarchy in IL- 1 induction-capacity: LPS greater than lipid A much greater than lipid A partial structures greater than core oligosaccharides greater than oligoacyl lipid A. Lipid A was shown here to be the portion of LPS mainly responsible for induction of IL-1 activity. The high potency of lipid A in inducing IL-1 release and the failure of the precursor Ia of lipid A to induce IL-1 production and release was also observed measuring intracellular IL-1 activity after freeze-thawing the cells. Levels of IL-1 beta mRNA in extracts of mononuclear cells correlated with biologic activity. In co-incubation experiments, precursor Ia of lipid A produced dose-dependent inhibition of production and release of IL-1 activity induced by lipid A or LPS, but not by Staphylococcus epidermidis or PHA. Incubation of cells with precursor Ia for 1h, followed by a medium change and further incubation of stimulus without precursor Ia of lipid A also resulted in inhibition. We conclude that lipid A is the main portion of LPS responsible for induction of IL-1, and that specific activation- and/or binding-mechanisms are involved in stimulation of cells with LPS and/or lipid A.


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
J. W. Jones, S. A. Shaffer, R. K. Ernst, D. R. Goodlett, and F. Turecek
Determination of pyrophosphorylated forms of lipid A in Gram-negative bacteria using a multivaried mass spectrometric approach
PNAS, September 2, 2008; 105(35): 12742 - 12747.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
N. Marr, A. Tirsoaga, D. Blanot, R. Fernandez, and M. Caroff
Glucosamine Found as a Substituent of Both Phosphate Groups in Bordetella Lipid A Backbones: Role of a BvgAS-Activated ArnT Ortholog
J. Bacteriol., June 15, 2008; 190(12): 4281 - 4290.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
H. Loppnow, K. Werdan, and M. Buerke
Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
Innate Immunity, April 1, 2008; 14(2): 63 - 87.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
P. Rallabhandi, A. Awomoyi, K. E. Thomas, A. Phalipon, Y. Fujimoto, K. Fukase, S. Kusumoto, N. Qureshi, M. B. Sztein, and S. N. Vogel
Differential Activation of Human TLR4 by Escherichia coli and Shigella flexneri 2a Lipopolysaccharide: Combined Effects of Lipid A Acylation State and TLR4 Polymorphisms on Signaling
J. Immunol., January 15, 2008; 180(2): 1139 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Ghanei, P. D. Abeyrathne, and J. S. Lam
Biochemical Characterization of MsbA from Pseudomonas aeruginosa
J. Biol. Chem., September 14, 2007; 282(37): 26939 - 26947.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
J.-M. Cavaillon and R. S. Munford
A tribute to Ernst Th. Rietschel: the gentleman scientist
Innate Immunity, February 1, 2007; 13(1): 3 - 5.
[PDF]

Home page
 Infect. Immun.Home page
J. Geurtsen, L. Steeghs, H.-J. Hamstra, J. ten Hove, A. de Haan, B. Kuipers, J. Tommassen, and P. van der Ley
Expression of the Lipopolysaccharide-Modifying Enzymes PagP and PagL Modulates the Endotoxic Activity of Bordetella pertussis.
Infect. Immun., October 1, 2006; 74(10): 5574 - 5585.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Marques, R. J. Rodrigues, A. C. de Magalhaes-Sant'Ana, and T. Goncalves
Saccharomyces cerevisiae Hog1 Protein Phosphorylation upon Exposure to Bacterial Endotoxin
J. Biol. Chem., August 25, 2006; 281(34): 24687 - 24694.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. M. Reynolds, A. A. Ribeiro, S. C. McGrath, R. J. Cotter, C. R. H. Raetz, and M. S. Trent
An Outer Membrane Enzyme Encoded by Salmonella typhimurium lpxR That Removes the 3'-Acyloxyacyl Moiety of Lipid A
J. Biol. Chem., August 4, 2006; 281(31): 21974 - 21987.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
M. S. Trent, C. M. Stead, A. X. Tran, and J. V. Hankins
Invited review: Diversity of endotoxin and its impact on pathogenesis
Innate Immunity, August 1, 2006; 12(4): 205 - 223.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
L. E. Cole, K. L. Elkins, S. M. Michalek, N. Qureshi, L. J. Eaton, P. Rallabhandi, N. Cuesta, and S. N. Vogel
Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity.
J. Immunol., June 1, 2006; 176(11): 6888 - 6899.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Rutten, J. Geurtsen, W. Lambert, J. J. M. Smolenaers, A. M. Bonvin, A. de Haan, P. van der Ley, M. R. Egmond, P. Gros, and J. Tommassen
Crystal structure and catalytic mechanism of the LPS 3-O-deacylase PagL from Pseudomonas aeruginosa
PNAS, May 2, 2006; 103(18): 7071 - 7076.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. R. H. Raetz, T. A. Garrett, C. M. Reynolds, W. A. Shaw, J. D. Moore, D. C. Smith Jr., A. A. Ribeiro, R. C. Murphy, R. J. Ulevitch, C. Fearns, et al.
Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4
J. Lipid Res., May 1, 2006; 47(5): 1097 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Wang, S. C. McGrath, R. J. Cotter, and C. R. H. Raetz
Expression Cloning and Periplasmic Orientation of the Francisella novicida Lipid A 4'-Phosphatase LpxF
J. Biol. Chem., April 7, 2006; 281(14): 9321 - 9330.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. C. Gangloff, U. Zahringer, C. Blondin, M. Guenounou, J. Silver, and S. M. Goyert
Influence of CD14 on Ligand Interactions between Lipopolysaccharide and Its Receptor Complex
J. Immunol., September 15, 2005; 175(6): 3940 - 3945.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
D.R. Dixon and R.P. Darveau
Lipopolysaccharide Heterogeneity: Innate Host Responses to Bacterial Modification of Lipid A Structure
Journal of Dental Research, July 1, 2005; 84(7): 584 - 595.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Geurtsen, L. Steeghs, J. t. Hove, P. van der Ley, and J. Tommassen
Dissemination of Lipid A Deacylases (PagL) among Gram-negative Bacteria: IDENTIFICATION OF ACTIVE-SITE HISTIDINE AND SERINE RESIDUES
J. Biol. Chem., March 4, 2005; 280(9): 8248 - 8259.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Mueller, K. Brandenburg, R. Dedrick, A. B. Schromm, and U. Seydel
Phospholipids Inhibit Lipopolysaccharide (LPS)-Induced Cell Activation: A Role for LPS-Binding Protein
J. Immunol., January 15, 2005; 174(2): 1091 - 1096.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Wang, M. J. Karbarz, S. C. McGrath, R. J. Cotter, and C. R. H. Raetz
MsbA Transporter-dependent Lipid A 1-Dephosphorylation on the Periplasmic Surface of the Inner Membrane: TOPOGRAPHY OF FRANCISELLA NOVICIDA LpxE EXPRESSED IN ESCHERICHIA COLI
J. Biol. Chem., November 19, 2004; 279(47): 49470 - 49478.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Mueller, B. Lindner, S. Kusumoto, K. Fukase, A. B. Schromm, and U. Seydel
Aggregates Are the Biologically Active Units of Endotoxin
J. Biol. Chem., June 18, 2004; 279(25): 26307 - 26313.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. M. Zughaier, Y.-L. Tzeng, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens
Neisseria meningitidis Lipooligosaccharide Structure-Dependent Activation of the Macrophage CD14/Toll-Like Receptor 4 Pathway
Infect. Immun., January 1, 2004; 72(1): 371 - 380.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. Karbarz, S. R. Kalb, R. J. Cotter, and C. R. H. Raetz
Expression Cloning and Biochemical Characterization of a Rhizobium leguminosarum Lipid A 1-Phosphatase
J. Biol. Chem., October 10, 2003; 278(41): 39269 - 39279.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Muroi and K.-i. Tanamoto
The Polysaccharide Portion Plays an Indispensable Role in Salmonella Lipopolysaccharide-Induced Activation of NF-{kappa}B through Human Toll-Like Receptor 4
Infect. Immun., November 1, 2002; 70(11): 6043 - 6047.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
H. Janusch, L. Brecker, B. Lindner, C. Alexander, S. Gronow, H. Heine, A. J. Ulmer, E. Th. Rietschel, and U. Zahringer
Structural and biological characterization of highly purified hepta-acyl lipid A present in the lipopolysaccharide of the Salmonella enterica sv. Minnesota Re deep rough mutant strain R595
Innate Immunity, October 1, 2002; 8(5): 343 - 356.
[Abstract] [PDF]

Home page
 Infect. Immun.Home page
K. Kawahara, H. Tsukano, H. Watanabe, B. Lindner, and M. Matsuura
Modification of the Structure and Activity of Lipid A in Yersinia pestis Lipopolysaccharide by Growth Temperature
Infect. Immun., August 1, 2002; 70(8): 4092 - 4098.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
I. C. Almeida and R. T. Gazzinelli
Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses
J. Leukoc. Biol., October 1, 2001; 70(4): 467 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
C. Alexander and E. Th. Rietschel
Invited review: Bacterial lipopolysaccharides and innate immunity
Innate Immunity, June 1, 2001; 7(3): 167 - 202.
[Abstract] [PDF]

Home page
 Innate ImmunityHome page
U. Zahringer, R. Salvetzki, F. Wagner, B. Lindner, and A. J. Ulmer
Structural and biological characterisation of a novel tetra-acyl lipid A from Escherichia coli F515 lipopolysaccharide acting as endotoxin antagonist in human monocytes
Innate Immunity, April 1, 2001; 7(2): 133 - 146.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
R. Blunck, O. Scheel, M. Muller, K. Brandenburg, U. Seitzer, and U. Seydel
New Insights Into Endotoxin-Induced Activation of Macrophages: Involvement of a K+ Channel in Transmembrane Signaling
J. Immunol., January 15, 2001; 166(2): 1009 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. G. Plotz, A. Lentschat, H. Behrendt, W. Plotz, L. Hamann, J. Ring, E. Th. Rietschel, H.-D. Flad, and A. J. Ulmer
The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent
Blood, January 1, 2001; 97(1): 235 - 241.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K.-i. Tanamoto and S. Azumi
Salmonella-Type Heptaacylated Lipid A Is Inactive and Acts as an Antagonist of Lipopolysaccharide Action on Human Line Cells
J. Immunol., March 15, 2000; 164(6): 3149 - 3156.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Matsuura, M. Kiso, and A. Hasegawa
Activity of Monosaccharide Lipid A Analogues in Human Monocytic Cells as Agonists or Antagonists of Bacterial Lipopolysaccharide
Infect. Immun., December 1, 1999; 67(12): 6286 - 6292.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K.-I. Tanamoto
Induction of Lethal Shock and Tolerance by Porphyromonas gingivalis Lipopolysaccharide in D-Galactosamine-Sensitized C3H/HeJ Mice
Infect. Immun., July 1, 1999; 67(7): 3399 - 3402.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Lentschat, V. T. El-Samalouti, J. Schletter, S. Kusumoto, L. Brade, E. T. Rietschel, J. Gerdes, M. Ernst, H.-D. Flad, and A. J. Ulmer
The Internalization Time Course of a Given Lipopolysaccharide Chemotype Does Not Correspond to Its Activation Kinetics in Monocytes
Infect. Immun., May 1, 1999; 67(5): 2515 - 2521.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Sugawara, R. Arakaki, H. Rikiishi, and H. Takada
Lipoteichoic Acid Acts as an Antagonist and an Agonist of Lipopolysaccharide on Human Gingival Fibroblasts and Monocytes in a CD14-Dependent Manner
Infect. Immun., April 1, 1999; 67(4): 1623 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. B. Schromm, K. Brandenburg, H. Loppnow, U. Zahringer, E. Th. Rietschel, S. F. Carroll, M. H. J. Koch, S. Kusumoto, and U. Seydel
The Charge of Endotoxin Molecules Influences Their Conformation and IL-6-Inducing Capacity
J. Immunol., November 15, 1998; 161(10): 5464 - 5471.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. Landmann, S. Link, S. Sansano, Z. Rajacic, and W. Zimmerli
Soluble CD14 Activates Monocytic Cells Independently of Lipopolysaccharide
Infect. Immun., May 1, 1998; 66(5): 2264 - 2271.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. A. Garrett, J. L. Kadrmas, and C. R. H. Raetz
Identification of the Gene Encoding the Escherichia coli Lipid A 4'-Kinase. FACILE PHOSPHORYLATION OF ENDOTOXIN ANALOGS WITH RECOMBINANT LpxK
J. Biol. Chem., August 29, 1997; 272(35): 21855 - 21864.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. A. Brozek, R. W. Carlson, and C. R.H. Raetz
A Special Acyl Carrier Protein for Transferring Long Hydroxylated Fatty Acids to Lipid A in Rhizobium
J. Biol. Chem., December 13, 1996; 271(50): 32126 - 32136.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
J.A. Rudbach, D.S. Keegan, and C.G. Sowell
Calculating therapeutic indices and therapeutic advantages for endotoxins and monophosphoryl lipid A: an evaluation of data from the scientific literature
Innate Immunity, August 1, 1995; 2(4): 301 - 310.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
R. L. Kitchens and R. S. Munford
Enzymatically Deacylated Lipopolysaccharide (LPS) Can Antagonize LPS at Multiple Sites in the LPS Recognition Pathway
J. Biol. Chem., April 28, 1995; 270(17): 9904 - 9910.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
P. Ridings, A.C. Windsor, D.P. Rossignol, W.J. Christ, C. Blocher, B.J. Fisher, A.A. Fowler, and H.J. Sugerman
A synthetic lipid A analog, B464, provides significant protection against the cardiopulmonary derangements in porcine Gram-negative sepsis
Innate Immunity, April 1, 1995; 2(2): 121 - 130.
[Abstract] [PDF]

Home page
 Innate ImmunityHome page
U. Schonbeck, H.-D. Flad, E. Th. Rietschel, E. Brandt, and H. Loppnow
S-form LPS induces leukocyte adhesion to human vascular endothelial cells as potent as IL-1: lipid A precursor Ia antagonizes induction of adhesion by LPS
Innate Immunity, March 1, 1994; 1(1): 4 - 13.
[Abstract] [PDF]

Home page
 Innate ImmunityHome page
H. Heine, H. Brade, S. Kusumoto, T. Kusama, E. Th. Rietschel, H.-D. Flad, and A.J. Ulmer
Inhibition of LPS binding on human monocytes by phosphonooxyethyl analogs of lipid A
Innate Immunity, March 1, 1994; 1(1): 14 - 20.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
N. L. S. Que, S. Lin, R. J. Cotter, and C. R. H. Raetz
Purification and Mass Spectrometry of Six Lipid A Species from the Bacterial Endosymbiont Rhizobium etli. DEMONSTRATION OF A CONSERVED DISTAL UNIT AND A VARIABLE PROXIMAL PORTION
J. Biol. Chem., September 1, 2000; 275(36): 28006 - 28016.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. S. Trent, W. Pabich, C. R. H. Raetz, and S. I. Miller
A PhoP/PhoQ-induced Lipase (PagL) That Catalyzes 3-O-Deacylation of Lipid A Precursors in Membranes of Salmonella typhimurium
J. Biol. Chem., March 16, 2001; 276(12): 9083 - 9092.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Poltorak, P. Ricciardi-Castagnoli, S. Citterio, and B. Beutler
Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation
PNAS, February 29, 2000; 97(5): 2163 - 2167.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.